Incomplete catch-up growth in low birthweight Chinese infants in Hong Kong
- PMID: 8554864
- DOI: 10.1111/j.1440-1754.1995.tb00852.x
Incomplete catch-up growth in low birthweight Chinese infants in Hong Kong
Abstract
Objective: To describe the early catch-up growth in length in Chinese low birthweight (< 2500 g) infants.
Methodology: The infants (n = 181) were delivered between 1988 and 1993 and followed up at Queen Mary and Tsan Yuk Hospitals, Hong Kong. One third had a birthweight below -2SDS, most of whom were term or close-to-term babies small-for-gestational-age (SGA). The remaining babies were appropriate-for-gestational-age (AGA) in birthweight, but frequently born prematurely.
Results: The SGA group did not show a catch-up growth in height comparable to that reported on other recent studies, as 33-35% of the patients were still short at 6 and 12 months (7-12% for the AGA group). When comparing the postnatal mean growth curve of the SGA group with the mean curve of the AGA group there was little sign of catch-up growth.
Conclusions: The results showed that Hong Kong SGA infants have an incomplete catch-up growth and for successful intervention the causative mechanisms have to be identified.
PIP: Small-for-gestational-age (SGA) infants have an increased risk of neonatal mortality and morbidity. That SGA infants comprise 20-25% of all short children attests to the fact that reduced fetal growth has a lifelong impact upon both development and survival. 70-90% of SGA infants, however, experience some catch-up growth during the first 6-12 months of life, but those infants who remain short by the end of the first year of life often do not experience later catch-up growth. Catch-up growth in SGA infants refers to a growth rate higher than the average rate of appropriate-for-gestational-age (AGA) infants. The authors describe the early catch-up growth in length among 181 Chinese low-birth-weight (LBW) infants delivered between 1988 and 1993, and followed up at Queen Mary and Tsan Yuk Hospitals, Hong Kong. A LBW baby weighs less than 2500 g at birth. The SGA babies in this study failed to show catch-up growth in height comparable to that reported in other recent studies; 33-35% remained short at ages 6 and 12 months. Comparing the postnatal mean growth curve of the SGA group with the mean curve of the AGA group revealed little indication of catch-up growth. Hong Kong SGA infants have an incomplete catch-up growth and for successful intervention, the causative mechanisms must be identified.
Similar articles
-
International comparisons of postnatal growth of low birthweight infants with special reference to differences between developing and affluent countries.Acta Paediatr Scand Suppl. 1982;296:14-8. doi: 10.1111/j.1651-2227.1982.tb09587.x. Acta Paediatr Scand Suppl. 1982. PMID: 6961734
-
Appropriate-for-gestational-age infants who exhibit reduced antenatal growth velocity display postnatal catch-up growth.PLoS One. 2020 Sep 8;15(9):e0238700. doi: 10.1371/journal.pone.0238700. eCollection 2020. PLoS One. 2020. PMID: 32898169 Free PMC article.
-
Effects of gestation and birth weight on the growth and development of very low birthweight small for gestational age infants: a matched group comparison.Arch Dis Child Fetal Neonatal Ed. 2000 May;82(3):F208-14. doi: 10.1136/fn.82.3.f208. Arch Dis Child Fetal Neonatal Ed. 2000. PMID: 10794788 Free PMC article.
-
Latin American consensus: children born small for gestational age.BMC Pediatr. 2011 Jul 19;11:66. doi: 10.1186/1471-2431-11-66. BMC Pediatr. 2011. PMID: 21771322 Free PMC article.
-
International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001.Pediatrics. 2003 Jun;111(6 Pt 1):1253-61. doi: 10.1542/peds.111.6.1253. Pediatrics. 2003. PMID: 12777538 Review.
Cited by
-
Comparative evaluation of short-term biomarker response to treatment for growth hormone deficiency in Chinese children with growth hormone deficiency born small for or appropriate for gestational age: a randomized phase IV open-label study.Ther Adv Endocrinol Metab. 2013 Apr;4(2):41-9. doi: 10.1177/2042018813484051. Ther Adv Endocrinol Metab. 2013. PMID: 23626901 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous